Internal Medicine, Hematology & Oncology · Westlake Village, CA
NPI
1619286101
Since 2010
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1250 la Venta Dr Ste 202
Westlake Village, CA, 91361
Phone (805) 496-5153
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
136,878 services
Medicare patients, 2024
651
Average age 75
Drug cost, 2024
$2.7M
693 prescriptions
Company payments, 2025
$327
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Julie Huynh was code Q0138 (injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)), 35,700 times for 33 patients. In total Julie Huynh billed 136,878 services in 136 codes, and Medicare paid $1.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-11-09.
| Code |
|---|
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| Q0138 Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | Office | 35,700 | 33 | $0.27 | $9,757 |
| J0897 Injection, denosumab, 1 mg | Office | 7,140 | 46 | $19.81 | $141K |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,300 | 15 | $0.11 | $685 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 6,000 | 12 | $44.67 | $268K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,130 | 32 | $0.08 | $88.11 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,010 | 24 | $0.65 | $654 |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 946 | 29 | $0.07 | $62.32 |
| 99214 Office E&M - Established | Office | 845 | 335 | $101.24 | $86K |
| 85025 Blood Count | Office | 675 | 248 | $7.40 | $4,992 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 566 | 370 | $13.28 | $7,517 |
| 96375 Injection Administration | Office | 465 | 66 | $11.63 | $5,409 |
| Q5108 Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | Office | 384 | 14 | $116.70 | $45K |
| J7050 Infusion, normal saline solution, 250 cc | Office | 280 | 68 | $0.49 | $137 |
| 96372 Injection Administration | Office | 276 | 91 | $11.83 | $3,266 |
| 96413 Chemotherapy Administration | Office | 260 | 74 | $110.93 | $29K |
By year: 2022 $2.1M for 199,185 services; 2023 $2.1M for 168,092 services; 2024 $1.9M for 136,878 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 675 | 248 | $7.40 | $4,992 |
| 36415 Venipuncture Blood Collection | 135 | 75 | $8.65 | $1,168 |
Medicare prescription drug claims, 2024
In 2024, the drug Julie Huynh prescribed most often to Medicare patients was Tamoxifen Citrate, with 134 prescriptions and refills. In total Julie Huynh wrote 693 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamoxifen Citrate Generic | 134 | 377 | 50 | $4,200 |
| Anastrozole Generic | 67 | 196 | 30 | $1,429 |
| Letrozole Generic | 57 | 165 | 26 | $1,606 |
| Prednisone Generic | 23 | 36 | 12 | $150 |
| Eliquis Apixaban | 19 | 29 | Under 11 | $16K |
| Hydroxyurea Generic | 19 | 51 | 11 | $284 |
| Raloxifene Hcl Generic | 18 | 46 | Under 11 | $774 |
| Ondansetron Hcl Generic | 18 | 18 | 18 | $584 |
| Kisqali Ribociclib Succinate | 16 | 16 | Under 11 | $222K |
| Tagrisso Osimertinib Mesylate | 16 | 16 | Under 11 | $264K |
| Xarelto Rivaroxaban | 16 | 34 | Under 11 | $18K |
| Elelyso Taliglucerase Alfa | 13 | 13 | Under 11 | $748K |
| Brukinsa Zanubrutinib | 11 | 11 | Under 11 | $130K |
| Fulvestrant Generic | 11 | 11 | Under 11 | $9,029 |
Brand drugs: - claims; generic drugs: 534 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Julie Huynh $327 ($327 in general payments such as food, travel and fees) from 3 companies. The largest payer was Syndax Pharmaceuticals, Inc. with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.